PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Cystic Fibrosis Centre, Department of Paediatrics, Jena University Hospital, Friedrich-Schiller-University, Am Klinikum 1, 07747, Jena, Germany.\', \'Institute of Medical Microbiology, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany.\', \'Institute for Infectious Diseases and Infection Control, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany.\', \'Cystic Fibrosis Centre, Department of Paediatrics, Jena University Hospital, Friedrich-Schiller-University, Am Klinikum 1, 07747, Jena, Germany. michael.lorenz@med.uni-jena.de.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s12890-022-01900-8
?:hasPublicationType
?:journal
  • BMC pulmonary medicine
is ?:pmid of
?:pmid
?:pmid
  • 35331203
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.373
?:rankingScore_hIndex
  • 46
is ?:relation_isRelatedTo_publication of
?:title
  • One year monitoring of SARS-CoV-2 prevalence in a German cohort of patients with cystic fibrosis.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all